En hier nog even hoe Michael Rhodin, ex IBM zijn commissariaat weergeeft op Linkedin:
Member Of The Supervisory Board; Audit Committee
Company NameTomTom
Dates EmployedFeb 2017 – Present Employment Duration6 mos
LocationAmsterdam Area, Netherlands
Member of the Supervisory Board for a leading edge B2B and Consumer company specializing in location based technologies, maps, navigation systems and consumer sporting devices.
En hij zit in de advisory board van:
Arboretum Ventures
Dates EmployedJun 2017 – Present Employment Duration2 mos
LocationAnn Arbor, Michigan
Member of the advisory board focusing on implications of digital technologies disrupting the healthcare industry.
Maar, op de site van Arboretum Ventures blijkt dat het eigenlijk een wat luxe benaming is voor een activistisch fonds dat zich begeeft in de health care markt:
"We are actively pursuing investments for Arboretum Ventures IV, a $220 million fund focused in the areas of medical devices, diagnostics, healthcare IT, and healthcare services. The criteria we use regarding stage, size of investment, and area of focus within healthcare are somewhat flexible. We like working with CEOs who have experience and domain expertise, but who also listen and are looking for a partner rather than just a source of capital. In general, we aim to invest $10-15 million, usually through multiple financing rounds.
Specifically, we seek companies that:
• Require less than $30-40 million to achieve an exit
• Have launched commercially or are within 2 years of commercialization
• Address “uncrowded” markets
• Demonstrate meaningful healthcare cost savings (20% or more)
• Reside in “under-ventured” geographies"
Dus, die zal er dan toch niet zitten vanwege de connectie met IBM?